Drug Profile
NNC 0070 002 0182
Alternative Names: NNC 0070-0002-0182Latest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Novo Nordisk
- Class Obesity therapies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Obesity
Most Recent Events
- 24 Sep 2014 Discontinued - Phase-I/II for Obesity (In volunteers) in USA (SC)